Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Xiaowu Wang, Bo Xu, Hongliang Liang, Shuyun Jiang, Hongmei Tan, Xinrong Wang, Xia Wang, Shiqiang Yu & Jincheng Liu. (2018) Distribution characteristics and factors influencing oral warfarin adherence in patients after heart valve replacement. Patient Preference and Adherence 12, pages 1641-1648.
Read now
Read now
Articles from other publishers (28)
Nasibeh Zerangian, Gisou Erabi, Mohadeseh Poudineh, Kosar Monajjem, Maryam Diyanati, Maryam Khanlari, Amirmohammad Khalaji, Diba Allafi, Arezoo Faridzadeh, Arian Amali, Nilufar Alizadeh, Yasaman Salimi, Sajjad Ghane Ezabadi, Amir Abdi, Zahra Hasanabadi, Mahdie ShojaeiBaghini & Niloofar Deravi. (2023) Venous thromboembolism in viral diseases: A comprehensive literature review. Health Science Reports 6:2.
Crossref
Crossref
Ziteng Wang & Eric Chun Yong Chan. (2022) Physiologically‐Based Pharmacokinetic Modeling‐Guided Dose Management of Oral Anticoagulants when Initiating Nirmatrelvir/Ritonavir (Paxlovid) for COVID‐19 Treatment. Clinical Pharmacology & Therapeutics 112:4, pages 803-807.
Crossref
Crossref
Theresa A. Reno, Lilas Tarnus, Russell Tracy, Alan L. Landay, Irini Sereti, Cristian Apetrei & Ivona Pandrea. (2022) The Youngbloods. Get Together. Hypercoagulation, Complement, and NET Formation in HIV/SIV Pathogenesis. Frontiers in Virology 1.
Crossref
Crossref
Alexey V. Kuzikov, Tatiana A. Filippova, Rami A. Masamrekh & Victoria V. Shumyantseva. (2022) Electrochemical determination of (S)-7-hydroxywarfarin for analysis of CYP2C9 catalytic activity. Journal of Electroanalytical Chemistry 904, pages 115937.
Crossref
Crossref
Dario Cattaneo, Dario Bernacchia, Martina Beltrami, Chiara Resnati, Paola Meraviglia & Cristina Gervasoni. (2021) When the absence of an interaction can become clinically relevant. AIDS 35:8, pages 1327-1328.
Crossref
Crossref
Chiara Agrati, Valentina Mazzotta, Carmela Pinnetti, Gianluigi Biava & Michele Bibas. (2021) Venous thromboembolism in people living with HIV infection (PWH). Translational Research 227, pages 89-99.
Crossref
Crossref
Dario Cattaneo, Tiziana Formenti, Antonio Gidaro, Andrea Merlo & Cristina Gervasoni. (2020) Use of Direct Oral Anticoagulants in People Living with HIV: A Single-Center Experience. Seminars in Thrombosis and Hemostasis 46:08, pages 999-1001.
Crossref
Crossref
Ozan Emre Eyupoglu. (2019) Measurements and monitorings dependent color intensity of drugs and food supplements interactions with textile dyes between TLC plates by using rope printing technique. Pharmacy & Pharmacology International Journal 7:5, pages 238-243.
Crossref
Crossref
Pilar Vizcarra, Silvia Guillemi, Oghenowede Eyawo, Robert S. Hogg, Julio S. Montaner & Matthew Bennett. (2019) Stroke and Systemic Thromboembolism Prevention in People Living With Human Immunodeficiency Virus With Atrial Fibrillation: A Review of Its Implications for Clinical Practice. CJC Open 1:5, pages 245-255.
Crossref
Crossref
Lauren J. Jonkman, Marvelous P. Gwanyanya, Monika N. Kakololo, Roger K. Verbeeck & Bonifasius S. Singu. (2019) Assessment of anticoagulation management in outpatients attending a warfarin clinic in Windhoek, Namibia. Drugs & Therapy Perspectives 35:7, pages 341-346.
Crossref
Crossref
Daniele Pastori, Ivano Mezzaroma, Pasquale Pignatelli, Francesco Violi & Gregory Y. H. Lip. (2019) Atrial fibrillation and human immunodeficiency virus type‐1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy. British Journal of Clinical Pharmacology 85:3, pages 508-515.
Crossref
Crossref
Lauren R. Cirrincione & Kimberly K. Scarsi. 2018. Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions. Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions
297
356
.
Katherine Hsin-Yu Chau, Rebecca Scherzer, Carl Grunfeld, Priscilla Ying Hsue & Michael G. Shlipak. (2017) CHA2DS2-VASc Score, Warfarin Use, and Risk for Thromboembolic Events Among HIV-Infected Persons With Atrial Fibrillation. JAIDS Journal of Acquired Immune Deficiency Syndromes 76:1, pages 90-97.
Crossref
Crossref
Alessandro Di Minno, Beatrice Frigerio, Gaia Spadarella, Alessio Ravani, Daniela Sansaro, Mauro Amato, Joseph P. Kitzmiller, Mauro Pepi, Elena Tremoli & Damiano Baldassarre. (2017) Old and new oral anticoagulants: Food, herbal medicines and drug interactions. Blood Reviews 31:4, pages 193-203.
Crossref
Crossref
Spencer H. Durham, Melissa E. Badowski, Michelle D. Liedtke, R. Chris Rathbun & Patricia Pecora Fulco. (2017) Acute Care Management of the HIV-Infected Patient: A Report from the HIV Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37:5, pages 611-629.
Crossref
Crossref
Andrew Stolbach, Karolina Paziana, Harry Heverling & Paul Pham. (2015) A Review of the Toxicity of HIV Medications II: Interactions with Drugs and Complementary and Alternative Medicine Products. Journal of Medical Toxicology 11:3, pages 326-341.
Crossref
Crossref
Brittany L. Good, Denese C. Gomes & Patricia P. Fulco. (2015) An unexpected interaction between warfarin and cobicistat-boosted elvitegravir. AIDS 29:8, pages 985-986.
Crossref
Crossref
Andrew S Tsiattalos & Anita Patel. (2014) Warfarin and boceprevir interaction causing subtherapeutic international normalized ratio: a case report. Journal of Medical Case Reports 8:1.
Crossref
Crossref
Riccardo Wanke, Shrika G. Harjivan, Sofia A. Pereira, M. Matilde Marques & Alexandra M.M. Antunes. (2013) The role of competitive binding to human serum albumin on efavirenz–warfarin interaction: a nuclear magnetic resonance study. International Journal of Antimicrobial Agents 42:5, pages 443-446.
Crossref
Crossref
J. S. Esterly, K. M. Darin, L. Gerzenshtein, F. Othman, M. J. Postelnick & K. K. Scarsi. (2013) Clinical implications of antiretroviral drug interactions with warfarin: a case-control study. Journal of Antimicrobial Chemotherapy 68:6, pages 1360-1363.
Crossref
Crossref
Elyse J. Singer, Miguel Valdes-Sueiras, Deborah L. Commins, William Yong & Margrit Carlson. (2013) HIV stroke risk: evidence and implications. Therapeutic Advances in Chronic Disease 4:2, pages 61-70.
Crossref
Crossref
Michelle D Liedtke, Amulya Vanguri & R Chris Rathbun. (2012) A Probable Interaction between Warfarin and the Antiretroviral TRIO Study Regimen. Annals of Pharmacotherapy 46:11, pages e34-e34.
Crossref
Crossref
Alice Tseng & Michelle Foisy. (2011) Important Drug-Drug Interactions in HIV-Infected Persons on Antiretroviral Therapy: An Update on New Interactions Between HIV and Non-HIV Drugs. Current Infectious Disease Reports 14:1, pages 67-82.
Crossref
Crossref
R. Chris Rathbun & Michelle D. Liedtke. (2011) Antiretroviral Drug Interactions: Overview of Interactions Involving New and Investigational Agents and the Role of Therapeutic Drug Monitoring for Management. Pharmaceutics 3:4, pages 745-781.
Crossref
Crossref
Edith Nutescu, Ittiporn Chuatrisorn & Erika Hellenbart. (2011) Drug and dietary interactions of warfarin and novel oral anticoagulants: an update. Journal of Thrombosis and Thrombolysis 31:3, pages 326-343.
Crossref
Crossref
B. Kirsch, H. Klinker & R. Huber. (2010) HIV in der Gef??chirurgieHIV in vascular surgery. Gef?sschirurgie 16:1, pages 38-43.
Crossref
Crossref
Tammy J. Bungard, Erin Yakiwchuk, Michelle Foisy & Cynthia Brocklebank. (2011) Drug Interactions Involving Warfarin: Practice Tool and Practical Management Tips. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada 144:1, pages 21-25.e9.
Crossref
Crossref
Brygida Knysz, Anna Szymanek, Tamara Gabryś, Jacek Gąsiorowski & Andrzej Gładysz. (2010) Therapeutic difficulties due to drug interactions of protease inhibitors with acenocoumarol in a HIV positive woman with Takayasu syndrome and pregnancy. A case report. HIV & AIDS Review 9:3, pages 83-85.
Crossref
Crossref